Literature DB >> 26428447

Myoclonus in the critically ill: Diagnosis, management, and clinical impact.

Raoul Sutter1, Anette Ristic2, Stephan Rüegg3, Peter Fuhr3.   

Abstract

Myoclonus is the second most common involuntary non-epileptic movement in intensive care units following tremor-like gestures. Although there are several types of myoclonus, they remain underappreciated, and their diagnostic and prognostic associations are largely ignored. This review discusses clinical, electrophysiological, neuroanatomical, and neuroimaging characteristics of different types of myoclonus in critically ill adults along with their prognostic impact and treatment options. Myoclonus is characterized by a sudden, brief, and sometimes repetitive muscle contraction of body parts, or a brief and sudden cessation of tonic muscle innervation followed by a rapid recovery of tonus. Myoclonus can resemble physiologic and other pathologic involuntary movements. Neurologic injuries, anesthetics, and muscle relaxants interfere with the typical appearance of myoclonus. Identifying "real myoclonus" and determining the neuroanatomical origin are important, as treatment responses depend on the involved neuroanatomical structures. The identification of the type of myoclonus, the involved neuroanatomical structures, and the associated illnesses is essential to direct treatment. In conclusion, the combined clinical, electrophysiological, and neuroradiological examination reliably uncovers the neuroanatomical sources and the pathophysiology of myoclonus. Recognizing cortical myoclonus is critical, as it is treatable and may progress to generalized convulsive seizures or status epilepticus.
Copyright © 2015 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Critical illness; Diagnosis; Myoclonus; Neurocritical care; Prognosis; Treatment

Mesh:

Year:  2015        PMID: 26428447     DOI: 10.1016/j.clinph.2015.08.009

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  12 in total

1.  Myoclonus After Cardiac Arrest: Where Do We Go From Here?

Authors:  Brin Freund; Peter W Kaplan
Journal:  Epilepsy Curr       Date:  2017 Sep-Oct       Impact factor: 7.500

Review 2.  Treatment of Movement Disorder Emergencies in Autoimmune Encephalitis in the Neurosciences ICU.

Authors:  Farwa Ali; Eelco F Wijdicks
Journal:  Neurocrit Care       Date:  2020-02       Impact factor: 3.532

3.  Comparison of the Effects of Low-Dose Midazolam, Magnesium Sulfate, Remifentanil and Low-Dose Etomidate on Prevention of Etomidate-Induced Myoclonus in Orthopedic Surgeries.

Authors:  Abbas Sedighinejad; Bahram Naderi Nabi; Mohammad Haghighi; Gelareh Biazar; Vali Imantalab; Siamak Rimaz; Zahra Zaridoost
Journal:  Anesth Pain Med       Date:  2016-04-02

Review 4.  Myoclonic Disorders.

Authors:  Olaf Eberhardt; Helge Topka
Journal:  Brain Sci       Date:  2017-08-14

Review 5.  Post-hypoxic Myoclonus: Current Concepts, Neurophysiology, and Treatment.

Authors:  Harsh V Gupta; John N Caviness
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2016-09-17

Review 6.  Post-hypoxic myoclonus: Differentiating benign and malignant etiologies in diagnosis and prognosis.

Authors:  Brin Freund; Peter W Kaplan
Journal:  Clin Neurophysiol Pract       Date:  2017-05-05

7.  A Moving Residual Limb: Botulinum Toxin to the Rescue.

Authors:  Marie-Michèle Briand; Mathieu Boudier-Réveret; Xavier Rodrigue; Geneviève Sirois; Min Cheol Chang
Journal:  Transl Neurosci       Date:  2020-02-29       Impact factor: 1.757

Review 8.  New-Onset Movement Disorders Associated with COVID-19.

Authors:  Pedro Renato P Brandão; Talyta C Grippe; Danilo A Pereira; Renato P Munhoz; Francisco Cardoso
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2021-07-08

9.  Movement disorders as a new neurological clinical picture in severe SARS-CoV-2 infection.

Authors:  P Cuhna; B Herlin; K Vassilev; A Kas; S Lehericy; Y Worbe; E Apartis; M Vidailhet; S Dupont
Journal:  Eur J Neurol       Date:  2020-09-14       Impact factor: 6.288

10.  Myoclonus in Patients With Coronavirus Disease 2019: A Multicenter Case Series.

Authors:  Pria Anand; Asma Zakaria; Karima Benameur; Charlene Ong; Maryann Putman; Sarah O'Shea; David Greer; Anna M Cervantes-Arslanian
Journal:  Crit Care Med       Date:  2020-11       Impact factor: 9.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.